Related Experiment Video
Updated: Jul 16, 2026

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes
Published on: November 1, 2011
Hematologist Bracha Ramot (1927-2006): Between the bedside and the bench
Laura Veronica Grunseid1, Nurit Kirsh1
1The Biological Thought Program, The Open University of Israel, Ra'anana, Israel.
The Hebrew University of Jerusalem opened the first medical school in Israel in May 1949. One of the select 45 students of its first class was Bracha (Chweidan) Ramot. After completing her medical studies with distinction, she went on to specialize in internal medicine and hematology and soon became a central figure in the development of hematology in Israel. In 1958, Ramot established the Hematological Institute at Tel-Hashomer hospital and served as its director until 1991. She devoted much of her time and effort to researching environmental and genetic factors that influence hematological conditions: deficiencies in coagulation factors, glucose metabolism disorders, and especially leukemias and lymphomas, including the type known as Hodgkin's disease. In 2001, Ramot, "The Doyenne of Israeli Hematology" as she was called in publications of the Albert Einstein Institute, was awarded the Israel Prize in Medical Sciences, the country's most prestigious prize. Her biography personifies the ability to overcome obstacles and challenges in one's personal life while concurrently becoming an exceedingly successful physician and researcher of extraordinary achievement.
The Hebrew University of Jerusalem opened the first medical school in Israel in May 1949. One of the select 45 students of its first class was Bracha (Chweidan) Ramot. After completing her medical studies with distinction, she went on to specialize in internal medicine and hematology and soon became a central figure in the development of hematology in Israel. In 1958, Ramot established the Hematological Institute at Tel-Hashomer hospital and served as its director until 1991. She devoted much of her time and effort to researching environmental and genetic factors that influence hematological conditions: deficiencies in coagulation factors, glucose metabolism disorders, and especially leukemias and lymphomas, including the type known as Hodgkin's disease. In 2001, Ramot, "The Doyenne of Israeli Hematology" as she was called in publications of the Albert Einstein Institute, was awarded the Israel Prize in Medical Sciences, the country's most prestigious prize. Her biography personifies the ability to overcome obstacles and challenges in one's personal life while concurrently becoming an exceedingly successful physician and researcher of extraordinary achievement.
Related Concept Videos
The Blood-brain Barrier
Bronsted-Lowry Acids and Bases
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

